These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 21429962

  • 1. The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function.
    Radavelli-Bagatini S, Blair AR, Proietto J, Spritzer PM, Andrikopoulos S.
    J Endocrinol; 2011 Jun; 209(3):307-15. PubMed ID: 21429962
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B, Radzikowska M, Wasilewska-Dziubińska E, Kapliński A, Roguski K, Płonowski A.
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Oct; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 5. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S.
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [Abstract] [Full Text] [Related]

  • 6. Involvement of GDF-9, leptin, and IGF1 receptors associated with adipose tissue transplantation on fertility restoration in obese anovulatory mice.
    Pereira M, Vidotti DB, Borra RC, Simões Mde J, Da Silva ID, Haidar MA.
    Gynecol Endocrinol; 2011 Oct; 27(10):759-66. PubMed ID: 21557698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB.
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [Abstract] [Full Text] [Related]

  • 12. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)?
    Chankiewitz E, Peschke D, Herberg L, Bazwinsky I, Mühlbauer E, Brömme HJ, Peschke E.
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):262-9. PubMed ID: 16804801
    [Abstract] [Full Text] [Related]

  • 13. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I.
    Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
    [Abstract] [Full Text] [Related]

  • 14. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome.
    Qiu S, Wu C, Lin F, Chen L, Huang Z, Jiang Z.
    Horm Metab Res; 2009 Dec; 41(12):880-5. PubMed ID: 19693748
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.